|
|
Volumn 9, Issue 3, 2003, Pages 319-326
|
|
Psychiatric Drug Discovery and Development Princeton, NJ, USA, June 23-24, 2003
|
|
Author keywords
Antidepressants; Antipsychotics; Anxiolytics; Drug development; Psychotherapeutics; Schizophrenia
|
|
Indexed keywords
1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE;
ACP 103;
AVE 1734;
AVE 5997;
DIAZEPAM;
DIZOCILPINE;
DOPAMINE 3 RECEPTOR BLOCKING AGENT;
DULOXETINE;
EGLUMETAD;
FLUOXETINE;
GLUCOCORTICOID;
L 76035;
METHAMPHETAMINE;
NEUROLEPTIC AGENT;
NEUROPEPTIDE;
NORADRENALIN UPTAKE INHIBITOR;
SEROTONIN 2A AGONIST;
SEROTONIN 2C AGONIST;
SEROTONIN UPTAKE INHIBITOR;
SNAP 7941;
TIANEPTINE;
TRANYLCYPROMINE;
UNCLASSIFIED DRUG;
WAY 161503;
CONFERENCE PAPER;
DEPRESSION;
HUMAN;
MENTAL DISEASE;
NONHUMAN;
OBESITY;
OBSESSIVE COMPULSIVE DISORDER;
PSYCHOTHERAPY;
SCHIZOPHRENIA;
UNITED STATES;
|
|
EID: 0141954289
PISSN: 1080563X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1527-3458.2003.tb00257.x Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|
